Reuters logo
BRIEF-Amgen's multiple Myeloma treatment in combination with Dexamethasone, receives NICE recommendation for use at first relapse
June 12, 2017 / 11:25 PM / 3 months ago

BRIEF-Amgen's multiple Myeloma treatment in combination with Dexamethasone, receives NICE recommendation for use at first relapse

June 12 (Reuters) - Amgen Inc

* Amgen’s multiple Myeloma treatment, Kyprolis® (Carfilzomib), in combination with Dexamethasone, receives NICE recommendation for use at first relapse

* NICE has published its FAD recommending Carfilzomib in combination with Dexamethasone as an option for treating adults with relapsed multiple Myeloma Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below